tirzepatide and nash hits two receptors. Semaglutide hits one. The liver feels the difference. Both drugs work in MASH. The question is whether the second receptor — GIP — adds meaningful hepatic benefit beyond Tirzepatide Beyond Diabetes and Obesity:

Non-GLP-1 medications for diabetes or weight management provide alternatives if this medication class proves intolerable

Yes, if not managed properly

Conclusion Determining whether to take GLP-1 at night or in the morning is a personal choice that depends on your lifestyle and how your body processes the medication

Many participants also experienced improvements in: Waist circumference Blood pressure Blood glucose Physical functioning Quality of life measures SELECT Trial The SELECT cardiovascular outcomes trial investigated semaglutide in adults with overweight or obesity and established cardiovascular disease

Supporting your body's natural glutathione production through sulfur-rich foods, antioxidant-rich fruits and vegetables, and healthy lifestyle habits provides a foundation that no supplement can replace

This would be the most highly efficacious drug ever approved for the treatment of obesity, said Dr